Clinical samples further confirmed the co-upregulation of NIBAN2, FLII, and RREB1 in GBM (Glioblastoma) tissues, which correlates with SOX2 and Ki-67 expression and poor prognosis. The gene discussed is MKI67; the disease is glioblastoma.